Description Group of viruses that cause gastrointestinal, respiratory, and systemic infections in humans and animals
Structure Parvoviruses are small, non-enveloped viruses containing a linear single-stranded DNA genome and belonging to the family Parvoviridae. The viral capsid possesses an icosahedral structure and lacks a lipid envelope, contributing to exceptional environmental stability and resistance to many common disinfectants. Members of the Parvoviridae family infect a wide range of vertebrate and invertebrate hosts and include important human and veterinary pathogens. Human Parvovirus B19 is the best-known human pathogen of the group and is the causative agent of erythema infectiosum (fifth disease). Other parvoviruses, such as canine parvovirus and feline panleukopenia virus, cause severe disease in animals. Parvoviruses preferentially infect rapidly dividing cells because they rely on host cellular machinery for viral DNA replication.
Diagnosis The diagnosis of parvovirus infection depends on the specific virus involved and may include serological, molecular, and antigen detection methods. Human Parvovirus B19 infection is commonly diagnosed through the detection of virus-specific IgM and IgG antibodies or by polymerase chain reaction (PCR) assays that identify viral DNA in blood or tissue samples. In veterinary medicine, infections such as canine parvovirus are frequently diagnosed using ELISA-based antigen detection tests on fecal samples, while PCR provides highly sensitive confirmation and strain identification. Laboratory findings and clinical presentation are often used in conjunction with specific diagnostic tests to establish the diagnosis.
Symptoms Parvovirus infections produce a broad spectrum of clinical manifestations depending on the host species and the specific virus involved. Human Parvovirus B19 infection commonly causes erythema infectiosum, characterized by a distinctive 'slapped-cheek' rash, mild fever, headache, and malaise. In adults, joint pain and arthritis-like symptoms may occur. In immunocompromised individuals or patients with underlying hematological disorders, severe anemia may develop due to infection of erythroid precursor cells. During pregnancy, fetal infection may result in hydrops fetalis or fetal loss. Animal parvoviruses, particularly canine parvovirus, commonly cause severe gastrointestinal disease characterized by vomiting, hemorrhagic diarrhea, dehydration, lethargy, and potentially fatal secondary infections.
Data
FAQ & Publications
Frequently Asked Questions
What is the intended application of the Parvovirus B19 IgM Control Serum BC122M?
The Parvovirus B19 IgM Control Serum BC122M is designed for use as an IgM control serum in ELISA assays, specifically pre-diluted and ready-to-use for SERION ELISA classic and SERION ELISA antigen assays.
How should the Parvovirus B19 IgM Control Serum BC122M be stored to maintain its stability?
The Parvovirus B19 IgM Control Serum BC122M should be stored refrigerated at 2-8°C to preserve its integrity and ensure reliable assay performance.
Publications
pmid
title
authors
citation
We haven't added any publications to our database yet.
Published literature highly relevant to the biological target of this product and referencing this antibody or clone are retrieved from the PubMed database provided by the United States National Library of Medicine at the National Institutes of Health.
Reviews
There are no reviews yet.